Amron Arthur H's Form 4 filing
Nephros Inc (NEPH) · filed May 30, 2024
- Accession no.
- 0001062993-24-011498
- Filed
- May 30, 2024
- Trade date
- May 28-30, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $11.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Amron Arthur HCIK 0001179697 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 28, 2024 | Common Stock | PPurchaseAcquired | +2,000 | $2.22 | +$4,440 | 100,463 | Direct | |
| May 30, 2024 | Common Stock | PPurchaseAcquired | +3,000 | $2.24 | +$6,720 | 103,463 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.